Denmark has suspended the use of Oxford/AstraZeneca vaccine for two weeks over concerns relating to blood clots.
Denmark who had already began the usage of Oxford/AstraZeneca Vaccines to combat the deadly virus, COVID-19, has now suspended the use of Oxford/AstraZeneca vaccine following some reported cases of blood clots among people who have received the vaccine.
This was confirmed in a statement signed by Søren Brostrøm, Director, National Board of Health, on Thursday.
The statement reads, “We are in the middle of the largest and most important vaccination rollout in Danish history. And right now we need all vaccines we can get. Therefore, putting one of the vaccines on pause is not an easy decision. But precisely because we vaccinated so many, we also need to respond with timely care when there is knowledge of possible serious side effects. We need to clarify this before we can continue to use the vaccine from AstraZeneca.”
Similarly, Magnus Heunicke, Danish Health Minister, took to his official Twitter handle to disclosed that the suspension of the usage of the vaccines is only a precautionary measure to observe the side effects of the vaccine.
He further stated that the health agencies haven’t specified that the reported cases of blood clot is connected to the vaccine.
He tweeted, “We act early, it needs to be thoroughly investigated.”
In similar terms, several European countries have suspended the use of Oxford/AstraZeneca vaccine.
On Monday, Austria announced that it has suspended the use of Oxford/AstraZeneca vaccine after a 49-year-old nurse reportedly died of severe clotting disorders days after receiving the vaccine.
Also, four other European countries – Estonia, Lithuania, Latvia and Luxembourg – also suspended vaccinations of doses from the same batch, which was delivered to 17 countries and included one million vaccines.
